U.K.: Cargill, Eagle Genomics Agree to Multi-Year Platform Engagement to Accelerate Microbiome Discovery
Life sciences and microbiome knowledge discovery company Eagle Genomics has announced that Cargill has signed a multi-year platform agreement to enable the digital transformation of microbiome and life sciences R&D across its global locations.
The deployment of the Eagle Genomics e[datascientist] platform will initially enable Cargill’s Health Technologies business to organize and synthesize additional insights from microbiome data amassed by the company over the past decade. “By revealing relationships between microbiome data entities and relevant multi-omics data, the platform will further enable Cargill to advance our understanding of the complex association between the microbiome and digestive and immune health in humans and animals,” said Mike Johnson, marketing director, Cargill Health Technologies.
“Healthy animals, healthy people and a healthy planet are all interconnected,” Johnson explained. “With the advanced knowledge and insights we anticipate generating from our microbiome data, the e[datascientist] will allow us to effectively build on our existing suite of health solutions and bring more relevant products to market in this exciting area of functional food.”
Continue reading at PR Newswire.
Get The Newsletter Today!
